China and US-based XtalPi has raised $61 million this year from investors impressed its use of quantum physics, computational chemistry, and artificial intelligence to bring greater certainty to drug development
The average cost of taking a drug from molecule to marketing approval is just under $2.6 billion, according to the Tufts Center for the Study of Drug Development. The process is also fraught with risk...
Cool Japan has taken a new angle on its cultural investment thesis with Spiber, a biotechnology developer bringing next-generation materials to the apparel industry
Creador has raised $50 million for its fourth Southeast Asia and India-focused private equity fund from the Asian Development Bank (ADB).
Everstone Group has established a partnership with Singapore-based warehouse operator GLP to invest $500 million in India’s logistics ecosystem.
Accel Partners and Qualcomm Ventures have joined an INR2.5 billion ($35 million) funding round for Indian agriculture industry platform operator Ninjacart.